Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A comparison between terminally radioiodinated hexadecenoic acid (I-HA) and 201Tl-thallium chloride in the dog heart. Implications for the use of I-HA for myocardial imaging.

Literature DB >> 7398671

A comparison between terminally radioiodinated hexadecenoic acid (I-HA) and 201Tl-thallium chloride in the dog heart. Implications for the use of I-HA for myocardial imaging.

G Westera, E E van der Wall, G A Heidendal, G C van den Bos.

Abstract

The regional myocardial distribution of 131I-16-iodo-9-hexadecenoic acid (131I-HA) and 201Tl-thallium chloride (201TlCl) was determined in normal dogs and after occlusion of a coronary artery. The uptake of 131I-HA was about 20% lower than that of 201TlCl but the ratio 201Tl/131I was the same for the whole myocardium within narrow limits for normal as well as infarcted tissue. The potential of 123I-HA as a radiopharmaceutical for diagnosis of myocardial defects is discussed.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1980 PMID： 7398671 DOI： 10.1007/bf00445621

Source DB: PubMed Journal: Eur J Nucl Med ISSN： 0340-6997

11 in total

1. Thallium-201 for myocardial imaging. Relation of thallium-201 to regional myocardial perfusion.

Authors: H W Strauss; K Harrison; J K Langan; E Lebowitz; B Pitt
Journal: Circulation Date: 1975-04 Impact factor: 29.690

2. Relationship between the reduction in coronary flow and the appearance of electrocardiographic changes.

Authors: R WEGRIA; M SEGERS
Journal: Am Heart J Date: 1949-07 Impact factor: 4.749

3. Spatial and temporal heterogeneity of left ventricular perfusion in awake dogs.

Authors: M L Marcus; R E Kerber; J C Erhardt; H L Falsetti; D M Davis; F M Abboud
Journal: Am Heart J Date: 1977-12 Impact factor: 4.749

4. Experimental myocardial imaging with 131 I-labeled oleic acid.

Authors: F J Bonte; K D Graham; J G Moore
Journal: Radiology Date: 1973-07 Impact factor: 11.105

5. Demonstration of myocardial infarction by photoscans of the heart in man.

Authors: R W Gunton; J R Evans; R G Baker; J C Spears; D S Beanlands
Journal: Am J Cardiol Date: 1965-10 Impact factor: 2.778

6. Synthesis of 123I-16-iodo-9-hexadecenoic acid and derivatives for use as myocardial perfusion imaging agents.

Authors: G D Robinson
Journal: Int J Appl Radiat Isot Date: 1977 Jan-Feb

7. Radioiodinated fatty acids for heart imaging: iodine monochloride addition compared with iodide replacement labeling.

Authors: G D Robinson; A W Lee
Journal: J Nucl Med Date: 1975-01 Impact factor: 10.057

8. Experimental basis of myocardial imaging with 123I-labeled hexadecenoic acid.

Authors: N D Poe; G D Robinson; L S Graham; N S MacDonald
Journal: J Nucl Med Date: 1976-12 Impact factor: 10.057

9. Myocardial imaging with 123I-hexadecenoic acid.

Authors: N D Poe; G D Robinson; F W Zielinski; W R Cabeen; J W Smith; A S Gomes
Journal: Radiology Date: 1977-08 Impact factor: 11.105

10. Comparative evaluation of fatty acids labeled with C-11, Cl-34m, Br-77, and I-123 for metabolic studies of the myocardium: concise communication.

Authors: H J Machulla; G Stöcklin; C Kupfernagel; C Freundlieb; A Höck; K Vyska; L E Feinendegen
Journal: J Nucl Med Date: 1978-03 Impact factor: 10.057

10 in total

1. The myocardial elimination rate of radioiodinated heptadecanoic acid.

Authors: F C Visser; G Westera; M J van Eenige; E E Van der Wall; W Den Hollander; J P Roos
Journal: Eur J Nucl Med Date: 1985

2. Myocardial kinetics of 123I-labeled-16-hexadecanoic acid.

Authors: R D Okada; D Elmaleh; G S Werre; H W Strauss
Journal: Eur J Nucl Med Date: 1983

3. Metabolic myocardial imaging with 123I-labeled heptadecanoic acid in patients with angina pectoris.

Authors: E E van der Wall; G A Heidendal; W den Hollander; G Westera; J P Roos
Journal: Eur J Nucl Med Date: 1981

Review 4. Cardiac metabolism: a technical spectrum of modalities including positron emission tomography, single-photon emission computed tomography, and magnetic resonance spectroscopy.

Authors: R Valkema; B L van Eck-Smit; E E van der Wall
Journal: J Nucl Cardiol Date: 1994 Nov-Dec Impact factor: 5.952

5. The elimination rate of 123I-heptadecanoic acid after intracoronary and intravenous administration.

Authors: F C Visser; M J van Eenige; E E van der Wall; G Westera; C J van Engelen; A van Lingen; C C de Cock; W den Hollander; G A Heidendal; J P Roos
Journal: Eur J Nucl Med Date: 1985

6. Dynamic myocardial scintigraphy with 123I-labeled free fatty acids in patients with myocardial infarction.

Authors: E E van der Wall; W den Hollander; G A Heidendal; G Westera; P A Majid; J P Roos
Journal: Eur J Nucl Med Date: 1981

7. A comparison between terminally radioiodinated hexadecenoic acid (125I-HA) and heptadecanoic acid (131I-H0A) in the dog heart.

Authors: E E van der Wall; G Westera; G A Heidendal; W den Hollander
Journal: Eur J Nucl Med Date: 1981-12